Imexpharm sees strong first half growth with $47 million in revenue

Imexpharm sees strong first half growth with $47 million in revenue

Imexpharm has reported strong first half results for 2025, with net revenue up 22 per cent on-year.
UK pharma scores $337 million trade boost in Vietnam

UK pharma scores $337 million trade boost in Vietnam

A Vietnamese legal reform could net British pharmaceutical firms up to $337 million in exports over the next five years.
Portfolio overhauls illustrate Vietnam’s potential

Portfolio overhauls illustrate Vietnam’s potential

Vietnam’s healthcare and pharmaceutical market has become heated as investors step up the restructuring of their investment portfolios.
CK Life Sciences' Cancer Vaccine Shows Promise Ahead of AACR 2025 Presentation

CK Life Sciences' Cancer Vaccine Shows Promise Ahead of AACR 2025 Presentation

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology.
LBB Specialties Teams Up with Kerry Group to Introduce Pharmaceutical Lactose to the Life Sciences Market

LBB Specialties Teams Up with Kerry Group to Introduce Pharmaceutical Lactose to the Life Sciences Market

LBB Specialties, a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new partnership with Kerry Group.
Is pharmaceutical market benefiting from EVFTA?

Is pharmaceutical market benefiting from EVFTA?

Known as one of Vietnam’s most notable new-generation trade deals, the EU-Vietnam Free Trade Agreement (EVFTA) marks a significant milestone in the 30-year journey of cooperation and development between both sides. Over five years of implementation, it has left a profound impact on Vietnam’s economy and its pharmaceutical market in particular.
Health M&As need careful navigation

Health M&As need careful navigation

Strong growth potential is expected to spur on mergers and acquisitions in Vietnam’s healthcare and pharmaceutical industry in 2025, but a more business-conducive environment is being called for so that the potential is actually reached.
Top 10 reputable pharmaceutical, medical supply companies in 2024 announced

Top 10 reputable pharmaceutical, medical supply companies in 2024 announced

The Vietnam Report JSC announced the list of top 10 reputable companies in the pharmacy, medical supply and health care for 2024.
Takeda honoured for contributions to Vietnam's sustainable development

Takeda honoured for contributions to Vietnam's sustainable development

With over a decade of pioneering solutions in Vietnam’s pharmaceutical sector, Takeda has been recognised for its contributions to sustainable development.
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

WuXi AppTec, has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Global Corporate Sustainability Assessment.
Attracting investment and international cooperation to unlock Vietnam's healthcare potential

Attracting investment and international cooperation to unlock Vietnam's healthcare potential

To achieve sustainable development in the healthcare and pharmaceutical sectors, Vietnam must adopt the strategy of 'go far, go together' through international cooperation and attracting foreign investment.
Innovation and biotechnology lead Vietnam’s healthcare development

Innovation and biotechnology lead Vietnam’s healthcare development

Health innovation and biotechnology could help Vietnam keep pace with global trends in healthcare.
Legal reform could woo foreign investment to pharmaceuticals

Legal reform could woo foreign investment to pharmaceuticals

Industry experts gave their views on how to attract foreign investment to the pharmaceutical sector at a VIR panel on September 25.
Pharma to experience robust growth

Pharma to experience robust growth

Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
Vietnam welcomes major Indian pharmaceutical investments

Vietnam welcomes major Indian pharmaceutical investments

Leading Indian pharmaceutical corporations have proposed significant investment in Vietnam.
|< < 1 2 3 4 > >|